CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Kimia Therapeutics
Kimia Therapeutics logo

Kimia Therapeutics

Empowering better medicine development through deep data insights and innovative tools.

Berkeley, CA, US🇺🇸
Founded
2023
Overview
Compare
Fundraising
Employees
Library

Kimia Therapeutics, founded with a mission to revolutionize drug discovery, focuses on leveraging deep data insights and innovative tools to develop better medicines. Their core product, ATLAS, integrates AcTive® Learning with Automated Synthesis and Screening, utilizing machine learning to expedite the identification of novel drugs. This technology aims to create a comprehensive chemical atlas of druggable space, thereby transforming the landscape of therapeutic target discovery and drug molecule identification.

Notable figures affiliated with Kimia Therapeutics include leading experts in machine learning and drug development. The company has attracted significant interest from prominent investors in the biotech sector. Key achievements include the successful integration of their ATLAS technology into the drug discovery process, which has led to the identification of several promising therapeutic targets. Overall, Kimia Therapeutics is making a substantial impact on the pharmaceutical industry by accelerating the development of effective treatments for human diseases.

Kimia Therapeutics - Similar Companies

Kalypsys logo

Kalypsys

kalypsys.com

Atommap logo

Atommap

Iambic Therapeutics logo

Iambic Therapeutics

iambic.ai

DeepCure logo

DeepCure

deepcure.ai

Insitro logo

Insitro

insitro.com

Deep Apple Therapeutics logo

Deep Apple Therapeutics

deepappletx.com

Superluminal Medicines logo

Superluminal Medicines

superluminalrx.com

Cognaisent logo

Cognaisent

cognaisent.com

Numerion Labs logo

Numerion Labs

numerionlabs.ai

Empress Therapeutics logo

Empress Therapeutics

empresstx.com

DeepBiome Therapeutics logo

DeepBiome Therapeutics

Terray Therapeutics logo

Terray Therapeutics

terraytx.com

Metis Therapeutics logo

Metis Therapeutics

metistx.com

Elucidata logo

Elucidata

elucidata.io

Kemia logo

Kemia

Kimia Therapeutics - Quick Facts

Who are Kimia Therapeutics' competitors?

Companies similar to Kimia Therapeutics include Kalypsys, Atommap, Iambic Therapeutics and DeepCure.

When was Kimia Therapeutics founded?

Kimia Therapeutics was founded in 2023.

Where is Kimia Therapeutics' headquarters located?

Kimia Therapeutics' headquarters is located in Berkeley, CA, US.

When was Kimia Therapeutics' last funding round?

Kimia Therapeutics' most recent funding round was for $55M (USD) in December 2023.

How much disclosed funding has Kimia Therapeutics raised?

As of Dec 19, 2023, Kimia Therapeutics has disclosed funding of $55M (USD). Undisclosed round amounts are excluded.

How many employees does Kimia Therapeutics have?

Kimia Therapeutics has 12 employees as of Feb 4, 2024.

Kimia Therapeutics - Classification

Ownership
  • Venture-backed
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Development
Tags
  • Biotech
  • Data
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software